Drawing for ESCALATE

USPTO serial 87489535

ESCALATE

Reviewed by CopyMark Law Group

Reg. 5462359Status 705Registered
Filing date
Status date
Registration date
May 8, 2018
Examiner
LAVOIE, RYAN CHRISTOPHER
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 705 means a Madrid-based U.S. registration has accepted Section 71 maintenance and Section 15 incontestability. The U.S. extension is active with strengthened rights. Track next renewal deadlines in TSDR and WIPO records.

Status 705: Status 705 means a Madrid-based U.S. registration has accepted Section 71 maintenance and Section 15 incontestability. The U.S. extension is active with strengthened rights.

Need help with ESCALATE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Todd A. Sullivan

Todd A. Sullivan Hayes Soloway P.C.175 Canal StreetManchester, NH 03101United States

Goods and services

ClassDescriptionStatusFirst use
001[ Biological and chemical reagents and preparations for laboratory and, scientific use; Biological and chemical preparations other than for medical or veterinary use for use in the determination of in-vitro properties of pharmaceutical substances, namely, Adsorption, Distribution, Metabolism, Excretion, or Toxicity (ADMET) properties of drug compounds and experimental drug candidates; reagent kits comprised of capture molecules namely serum albumin immobilized to beads of different composition, as well as buffer solutions for scientific or medical research purposes; assays for scientific or medical research purposes; assays and reagent kits comprised of capture molecules namely serum albumin immobilized to beads of different composition, as well as buffer solutions for use in binding of pharmaceutical development candidates to plasma proteins ]SECTION 8 - CANCELLED—
042Custom design and development of biological and chemical reagents and biochemical assays; scientific research; scientific analysis services, namely in vitro analysis service for pharmaceutical research and development; scientific testing services in the field of pharmaceutical research and development; scientific laboratory services; [ scientific consultancy in the field of pharmaceutical research and development, research services in the field of pharmaceutical research and development; ] research services in the field of assaying binding of pharmaceutical development candidates to plasma proteinsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 3, 2024NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Oct 3, 2024C15PREGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Oct 3, 2024APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Apr 2, 2024E815TEAS SECTION 8 & 15 RECEIVED—
May 8, 2023REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
May 8, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 20, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 20, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 31, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 11, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 12, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 11, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 11, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 13, 2017GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 13, 2017GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 13, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 13, 2017DOCKASSIGNED TO EXAMINER—
Jul 31, 2017AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Jul 27, 2017ALIEASSIGNED TO LIE—
Jun 23, 2017PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Jun 21, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 17, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance